182 related articles for article (PubMed ID: 12399190)
1. Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine.
Terada K; Niizuma T; Ogita S; Kataoka N
Vaccine; 2002 Nov; 20(31-32):3638-43. PubMed ID: 12399190
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older.
Levine MJ; Ellison MC; Zerbe GO; Barber D; Chan C; Stinson D; Jones M; Hayward AR
Vaccine; 2000 Jun; 18(25):2915-20. PubMed ID: 10812235
[TBL] [Abstract][Full Text] [Related]
3. High-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccine.
Sarkadi J; Jankovics M; Fodor K; Kis Z; Takacs M; Visontai I; Jankovics I; Gonczol E
Clin Vaccine Immunol; 2015 May; 22(5):570-7. PubMed ID: 25787138
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
6. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
[TBL] [Abstract][Full Text] [Related]
7. Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine.
Sperber SJ; Smith BV; Hayden FG
Antiviral Res; 1992 Mar; 17(3):213-22. PubMed ID: 1314536
[TBL] [Abstract][Full Text] [Related]
8. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
[TBL] [Abstract][Full Text] [Related]
9. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
[TBL] [Abstract][Full Text] [Related]
10. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
Gershon AA; Steinberg SP
J Infect Dis; 1990 Apr; 161(4):661-6. PubMed ID: 2156941
[TBL] [Abstract][Full Text] [Related]
12. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
13. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to varicella-zoster virus after natural or vaccine-induced infection.
Bogger-Goren S; Baba K; Hurley P; Yabuuchi H; Takahashi M; Ogra PL
J Infect Dis; 1982 Aug; 146(2):260-5. PubMed ID: 6286790
[TBL] [Abstract][Full Text] [Related]
16. Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.
Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Jose L; Koen A; Moultrie A; Grobbee DE; Klipstein-Grobusch K; Weinberg A; Madhi SA
Vaccine; 2020 May; 38(22):3862-3868. PubMed ID: 32307279
[TBL] [Abstract][Full Text] [Related]
17. Varicella Virus Vaccination in the United States.
Shaw J; Gershon AA
Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination.
Habermehl P; Lignitz A; Knuf M; Schmitt HJ; Slaoui M; Zepp F
Vaccine; 1999 Feb; 17(7-8):669-74. PubMed ID: 10067672
[TBL] [Abstract][Full Text] [Related]
19. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
[TBL] [Abstract][Full Text] [Related]
20. Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels.
Tourtelot E; Quataert S; Glantz JC; Perlis L; Muthukrishnan G; Mosmann T
Vaccine; 2020 Feb; 38(7):1581-1585. PubMed ID: 31959424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
